The latest board meeting for Eton Pharma Inc took place on 14 May 2026, for the purpose of Eton Pharmaceuticals Inc First Quarter Earnings Conference Call for 2026See details
Eton Pharma Inc has a share price target of US$ 41, revenue growth forecast of 42.1%, and profit growth estimate of 668.0% for FY26, based on top 3 analyst calls.